Connecticut Mental Health Inpatient Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Connecticut’s licensing rules for behavioral health hand out deemed status exactly once, and it goes to psychiatric hospitals. Under a hospital rule that took effect April 18, 1978, a hospital for mentally ill persons accredited by the Joint Commission as a psychiatric hospital “shall be deemed to meet the requirements of these regulations” once it lets the accreditor release its current survey to the Department of Public Health (DPH) (Regs. Conn. State Agencies 17-227-14b(H)). The residential mental health rules below hospital level contain nothing like it. And whichever setting you choose, a new mental health facility in Connecticut is a health care facility for Certificate of Need purposes, a program that DPH took over on July 1, 2026.

Connecticut’s Inpatient and Residential Mental Health Settings

Every cell paraphrases the DPH-hosted rule text or statute cited in it.

The intermediate treatment facility is named in the title of rule 19a-495-550 and defined as a place offering “evaluative, diagnostic, and treatment services in a residential setting” for conditions that “do not require a hospital level of treatment.” It does not appear as its own line on FLIS’s list of licensed types, so which category FLIS would license a given residential program under is a question to settle with the section before you design around it.

Deemed Status for Psychiatric Hospitals, and Its Limits

Quoted from DPH’s copy of the Public Health Code section on hospitals for mentally ill persons.

The rule defines its subject as “a psychiatric facility which primarily offers medically directed inpatient services for the diagnosis, treatment, care, protection and rehabilitation” of people admitted with psychiatric disorders (17-227-14a(G)). Three conditions open the deemed-status door in 17-227-14b(H)(1): Joint Commission accreditation as a psychiatric hospital, the hospital’s authorization for the Commission to release the most current survey to DPH on a confidential basis when DPH asks, and handing DPH whatever documentation it needs to check compliance with state and local law. The limits are just as specific. A deemed hospital “must make application for a license” like anyone else. The benefit falls away if a DPH inspection turns up significant deficiencies. And the rule still names the “joint commission on accreditation of hospitals,” so confirm with FLIS how it treats today’s Joint Commission psychiatric hospital accreditation before you build a survey strategy on it.

The same rule says hospital licenses “terminate annually on the 31st of December.” The statute that came later, 19a-493(a), makes licenses valid “for two years or a fraction thereof,” and our reading is that the statute governs. Licenses can’t be transferred (17-227-14b(D)), and a hospital keeps “A single, compiled, written record for each patient” (17-227-14m(A)).

Certificate of Need Comes Before the License

Section 19a-630(10) lists “mental health facilities” among health care facilities, and 19a-638(a) requires CON both to establish a new one and to increase licensed bed capacity. Section 19a-638(b)(23) did exempt some bed increases at existing mental health facilities, but only increases made “On or before June 30, 2026,” and the Office of Legislative Research’s summary of this year’s health acts reports no extension for private facilities. As we read the statute today, added beds need CON again, and a for-profit psychiatric hospital or residential program gets no exemption that we found. A nonprofit that “has a contract with, or is certified or licensed to provide a service for, a state agency” is a different case under 19a-638(b)(14), so ask DPH whether that reaches your project. Applications go through DPH’s Certificate of Need program, which DPH says it has run since July 1, 2026 under Public Act 26-68, through its CON portal at dphconwebportal.ct.gov, with public comments to concomment@ct.gov.

Filing With FLIS

There is no online form for a new facility license. The packet comes on request from DPH.FLISLPU@ct.gov, the address FLIS’s licensing page gives for initial and ownership-change applications, and the hospital rule calls for a written application “on forms provided by the department” (17-227-14b(B)(1)). The FLIS page also posts the ownership forms, the local fire marshal’s certificate of inspection, an attestation of licensure applicant and a sample certificate of insurance. No initial license goes out until DPH has done what 19a-493(a) calls “a scheduled inspection and investigation.” For a change of ownership, 19a-493(c) requires DPH’s prior approval and an application at least 120 days ahead. FLIS answers at 860-509-7400.

Plan the incident reporting setup into the opening checklist too. DPH’s Reportable Events page lists residential living centers and community residences among the program types that switched from phone calls to online event reports in September 2024. Under rules 550(j) and 551(j), Class A covers an event that caused serious injury or death or could have, Class B covers an interruption of services, and Class C covers legal action against the facility. Class A and B events are reported immediately, with the written report due within 72 hours.

Ketamine on a Connecticut Psychiatric Unit or Residential Program

Ketamine isn’t named in any Connecticut licensing rule we read. Applying the hospital and residential rules to it is our own interpretation of the provisions cited, and the federal points come from the regulations and FDA label listed under Sources.

A psychiatric hospital is the one setting in this guide where we would start a ketamine or esketamine course on site. Federal law puts ketamine in Schedule III (21 CFR 1308.13(c)(7)). The Connecticut hospital rule already requires “a program for the control and accountability of drug products,” a registered pharmacist in charge of pharmacy services, and written policies for “the safe ordering, dispensing and administration of drugs” (17-227-14h). A Medicare-participating hospital also works under 42 CFR 482.25, which says “A formulary system must be established by the medical staff” and requires current records “of the receipt and disposition of all scheduled drugs.” In practice that means the medical staff’s pharmacy committee decides whether ketamine goes on the formulary, then the psychiatrists’ privileges and a nursing observation protocol follow. With an RN on duty at all times under 17-227-14g, the nursing piece has a footing. We found no position from the Connecticut Board of Examiners for Nursing on RN-administered ketamine. The nurse practice act describes RN work as “executing the medical regimen under the direction of a licensed physician, dentist or advanced practice registered nurse” (20-87a(a)), so standing orders from the prescribing psychiatrist matter.

Registration is the next layer. Connecticut’s Department of Consumer Protection requires a controlled substance registration from “every practitioner who distributes, administers or dispenses any controlled substance” (21a-317), and the registration is location specific. DCP also says DEA expects that state registration before it issues a new DEA number with a Connecticut address. Spravato adds a federal layer: the label says it “can only be administered at healthcare settings certified in the SPRAVATO REMS program,” and its patient guide has a provider watch the patient for no less than two hours post-dose. Whether in-hospital administered doses must be reported to the Connecticut Prescription Monitoring and Reporting System isn’t answered by the statute or DCP page we read (21a-254(j) speaks of dispensed prescriptions and excludes drugs dispensed to hospital inpatients), so ask DCP.

Consent deserves a slower look on a psychiatric unit. The hospital rule ties licensees to the state’s patient bill of rights (17-227-14l(A)) without spelling out how medication consent works for a committed patient. Our approach would open a ketamine protocol only to voluntary patients who can give informed consent, and leave any wider use to hospital counsel.

Below hospital level the answer changes. A residential living center has no nurse requirement and a 1:8 staffing ratio, which was never meant for post-dose observation, so residents who are candidates should receive ketamine at an outside clinic and come home with staff aware a dose was given that day. An intermediate treatment facility must keep a licensed nurse on duty and awake at all times (19a-495-550(k)(5)(I)), which gives post-dose observation more footing, but adding a new medical service there is, in our reading, a change in services that DPH has to hear about in writing 90 days or more ahead (19a-495-550(b)(4)(F)).

Handing the Series to an Outpatient Prescriber

A ketamine series usually outlasts a hospital stay. Pick the outpatient prescriber during the first week, get the patient’s signed release, and attach the dosing log and a note on how the patient responded to the discharge summary. Who can own that outpatient practice is less settled in Connecticut than in many states: nothing we searched (statutes, rules, appellate cases) forbids a non-clinician from owning a medical practice outright, but if the owners pick a professional corporation, every shareholder has to hold the relevant license (33-182a and 33-182c). The ownership options and the clinic licensing question are in the ketamine section of Connecticut Drug and Alcohol Outpatient Treatment Licensing.

Staffing Costs for a Connecticut Psychiatric or Residential Program

The hospital rule’s fixed positions are a psychiatrist on the medical staff, an RN Director of Nursing Services, an RN on duty around the clock and a registered pharmacist over pharmacy services. A residential living center needs a director with a bachelor’s degree and three years of experience and enough staff to hold 1:8. Therapy staff is where the budget moves most. BLS reports a $63,590 median for Connecticut substance abuse, behavioral disorder and mental health counselors, a 25th percentile of $49,250 and a 75th of $80,040 (BLS OEWS, May 2025), above the $59,350 national median. A five-person therapy team paid at the state median costs $317,950 a year by our arithmetic, about $318,000 before nursing, psychiatry and benefits. That figure assumes every therapist is fully licensed, and most Connecticut programs don’t have to staff that way. A licensed clinical director supervising graduate interns and clinicians still completing their board’s supervised hours, paid below fully licensed rates while they finish, usually shaves 40 to 60 percent off clinical payroll relative to filling every chair with a fully licensed clinician. On the substance use side, 20-74s exempts student interns and supervised paid counselors from the counselor license. The rule asks for one RN on duty at all times, so pairing that RN with LPNs for the rest of the nursing coverage, rather than an all-RN schedule, is a second lever. Bed count and acuity set the real roster.

What Slows Connecticut Mental Health Projects

CON comes first on the list, mostly because operators from states without it budget no time for it. The second is picking a category late. A program designed as a “residential treatment” model and only later matched to MHRL, MHCR or an intermediate treatment facility often finds its staffing or nursing assumptions don’t fit the rule it lands in. The third is hospitals counting on deemed status without confirming with FLIS that the accreditor will release the survey and that DPH reads the 1978 rule the way they do.

Frequently Asked Questions

Weighing a psychiatric hospital against a residential program in Connecticut? Start the conversation here.

Sources

• Department of Consumer Protection, Prescription Monitoring Program prescriber information: CPMRS prescriber information (checked October 13, 2026)
• Regs. Conn. State Agencies 17-227-14a to 17-227-14m, DPH Public Health Code copy: Licensure of hospitals for mentally ill persons (PDF) (checked October 13, 2026)
• Regs. Conn. State Agencies 19a-495-550, via Cornell LII: Day treatment, intermediate treatment and psychiatric outpatient clinics for adults (checked October 13, 2026)
• Regs. Conn. State Agencies 19a-495-551, DPH Public Health Code copy: Mental health residential living centers (PDF) (checked October 13, 2026)
• Regs. Conn. State Agencies 19a-495 index, via Cornell LII (19a-495-560 to -569 title): Section 19a-495 index (checked October 13, 2026)
• DPH Facility Licensing and Investigations Section, Facility Licensing (categories, application requests, forms, eLicense renewals, contacts): FLIS Facility Licensing (checked October 13, 2026)
• DPH FLIS, Reportable Events (web reporting since September 18, 2024, 72-hour submission): Reportable Events (checked October 13, 2026)
• DPH, Certificate of Need (transfer to DPH July 1, 2026, Public Act 26-68): Certificate of Need (checked October 13, 2026)
• Conn. Gen. Stat. 19a-490, via Justia: Definitions (checked October 13, 2026)
• Conn. Gen. Stat. 19a-491, via Justia: License required, fees (checked October 13, 2026)
• Conn. Gen. Stat. 19a-493, via Justia: License term, inspections, change of ownership (checked October 13, 2026)
• Conn. Gen. Stat. 19a-630, via Justia: CON definitions (checked October 13, 2026)
• Conn. Gen. Stat. 19a-638, via Justia: Certificate of Need required (checked October 13, 2026)
• Conn. Gen. Stat. chapter 368z, official 2026 Supplement (19a-638 not amended in 2025): 2026 Supplement, chapter 368z (checked October 13, 2026)
• Office of Legislative Research, 2026 Acts Affecting Health Professions and Institutions (2026-R-0080): OLR report (PDF) (checked October 13, 2026)
• Conn. Gen. Stat. 20-74s, via Justia: Alcohol and drug counselors (checked October 13, 2026)
• Conn. Gen. Stat. 20-87a, via Justia: Nursing practice, APRN collaboration (checked October 13, 2026)
• Conn. Gen. Stat. 21a-317, via Justia: Controlled substance registration (checked October 13, 2026)
• Conn. Gen. Stat. 21a-254, via Justia: Prescription monitoring reporting (checked October 13, 2026)
• Department of Consumer Protection, Controlled Substance Registration for Practitioner FAQ: CSR FAQ (checked October 13, 2026)
• Conn. Gen. Stat. chapter 594a (33-182a, 33-182c), official 2025 text: Professional service corporations (checked October 13, 2026)
• 21 CFR 1308.13(c)(7), via Cornell LII: Ketamine in Schedule III (checked October 13, 2026)
• U.S. FDA, Spravato prescribing information and Medication Guide: Spravato label (PDF) (checked October 13, 2026)
• 42 CFR 482.25, via Cornell LII: Hospital pharmaceutical services (checked October 13, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025, SOC 21-1018: OEWS tables (checked October 13, 2026)